Lumicell
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
275 Washington St Ste 200, Newton, Massa...Phone Number
(617) 404-1001Website
www.lumicell.comRevenue
$18.9 MillionIndustry
About Lumicell
Lumicell is dedicated to transforming cancer surgery through its innovative fluorescence imaging technology, which illuminates residual cancer in real-time during procedures. The company has recently received FDA approval for its LUMISIGHT and Lumicell DVS products, enhancing the effectiveness of cancer excision. Targeting healthcare professionals and institutions involved in cancer treatment, Lumicell aims to improve surgical outcomes for breast cancer patients. Their LumiSystem is designed to facilitate intraoperative assessments, ensuring more complete cancer removal.Explore more
Lumicell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Lumicell
Compare insights from companies similar to Lumicell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lumicell
$18.9M
11-50
Private
$42.7M
2009
KK
Kevin KrenitskyChief Operating Officer and CCO, Foundation Medicine
<$5M
11-50
Private
-
2007
JB
Jeannette BakkenNetwork Administrator & Clinical Database Programmer & Contractor
Lumicell Tech Stack
A closer look at the technologies used by Lumicell
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lumicell
Sign Up For FreeTo access detailed company insights
Lumicell is dedicated to transforming cancer surgery through its innovative fluorescence imaging technology, which illuminates residual cancer in real-time during procedures. The company has recently received FDA approval for its LUMISIGHT and Lumicell DVS products, enhancing the effectiveness of cancer excision. Targeting healthcare professionals... Read More
